Key result
Renal sympathetic denervation fails to control symptoms or admissions in refractory multivessel coronary spasm.
Why the study?
Evidence to guide management of refractory multivessel coronary artery spasm unresponsive to calcium channel blockers and nitrates is scarce, and the role of renal sympathetic denervation is unclear.
Case Report (n=1)
Renal sympathetic denervation was ineffective in controlling symptoms in a patient with refractory multivessel coronary artery spasm, highlighting the challenge of managing this condition.
Does not support renal denervation for refractory multivessel spasm; single case leaves autonomic modulation efficacy unresolved.
Background and Clinical Significance: Multivessel coronary artery spasm (CAS) is an uncommon, high-risk form of vasospastic angina that can produce transient ST-segment elevation mimicking acute myocardial infarction. Evidence to guide management when calcium channel blockers and nitrates fail is scarce, and renal sympathetic denervation (RSD) has been reported in very few patients; Case Presentation: A 53-year-old man with hypertension, type 2 diabetes, and dyslipidemia presented with nocturnal chest pain and inferior ST-segment elevation. Coronary angiography showed severe spontaneous spasm of the right coronary and left anterior descending arteries that resolved completely with intracoronary nitrate; the coronary arteries were otherwise angiographically normal. High-sensitivity cardiac troponin I remained below 10 ng/L (reference 0–34 ng/L), and echocardiography was normal, fulfilling the criteria for definite vasospastic angina without myocardial infarction. The same two-vessel spasm was documented at a second angiogram three months later. Despite maximally tolerated dual calcium channel blockade, nitrates, and statin therapy, he required more than ten further admissions. A self-terminating accelerated idioventricular rhythm lasting about two minutes was recorded. No syncope or malignant arrhythmia occurred, and an electrophysiology review found no current indication for an implantable cardioverter–defibrillator. Radiofrequency RSD was performed off-label for refractory symptoms without complications, but at six months, his symptoms and admissions were unchanged; Conclusions: Our case highlights the diagnostic and therapeutic difficulties in refractory CAS. Accelerated idioventricular rhythm after relief of spasm is a reperfusion rhythm and does not by itself indicate device therapy. In this patient, RSD did not control refractory multivessel CAS, a negative observation that adds to the very limited evidence on autonomic modulation in this setting.
No takes yet. Share an insight, caveat, or question.
Bahlani et al. (2026) conducted a case report in Refractory multivessel coronary artery spasm (n=1). Radiofrequency renal sympathetic denervation was evaluated on Symptom control and hospital admissions. Radiofrequency renal sympathetic denervation failed to control refractory symptoms and admissions at 6 months in a patient with multivessel coronary artery spasm.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: